Malignant primary female genital system lymphoid

Qiucheng Jia; Huimin Tang; Zhiyong Dong; Wanying Chen; Mengyue Chen; Weiwei Wei; Jiming Chen

doi:10.3389/fonc.2024.1438812

Malignant primary female genital system lymphoid

Front Oncol. 2024 Sep 26:14:1438812. doi: 10.3389/fonc.2024.1438812. eCollection 2024.

Authors

Qiucheng Jia¹, Huimin Tang², Zhiyong Dong³, Wanying Chen¹, Mengyue Chen¹, Weiwei Wei¹, Jiming Chen¹

Affiliations

¹ Department of Gynecology, The Affiliated Changzhou Second People's Hospital of Nanjing Medical University, Changzhou, China.
² Suqian First People's Hospital of Nanjing Medical University, Suqian, Jiangsu, China.
³ Department of Obstetrics and Gynaecology, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, China.

Abstract

Lymphoma is a malignant tumour of the lymphatic system with an incidence rate of about 6.6 per 100,000 people. Among the many lymphoma types, the most common is non-Hodgkin's lymphoma. Lymphomas are common in the gastrointestinal tract, breast, neck, etc., while those in female genital tracts are rare. In this article, we report four cases of primary female genital system lymphoid malignancies diagnosed and treated at our hospital from 2018 to 2023, with a systematic review.

Keywords: non-Hodgkin’s lymphoma; ovarian lymphoma; primary female genital system lymphoma; uterine lymphoma; vulvar lymphoma.

Publication types

Review

Grants and funding

The author(s) declare financial support was received for the research, authorship, and/or publication of this article. This work was supported by grants from Top Talent of Changzhou “The 14th Five-Year Plan” High-Level Health Talents Training Project (2022CZBJ074), the maternal and child health key talent project of Jiangsu Province (RC202101), the maternal and child health research project of Jiangsu Province (F202138), the Scientific Research Support Program for Postdoctoral of Jiangsu Province (2019K064), and the Scientific Research Support Program for “333 Project” of Jiangsu Province (BRA2019161).